Twilight Bioscience

Twilight Bioscience develops active immunotherapy for chronic diseases, including an immunotherapy targeting the envelope protein of human endogenous retrovirus K (HERV-K) for ALS. Source

Keywords: immunotherapy chronic diseases HERV-K ALS